These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 18587388)

  • 1. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.
    Yuzwa SA; Macauley MS; Heinonen JE; Shan X; Dennis RJ; He Y; Whitworth GE; Stubbs KA; McEachern EJ; Davies GJ; Vocadlo DJ
    Nat Chem Biol; 2008 Aug; 4(8):483-90. PubMed ID: 18587388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation.
    Yu Y; Zhang L; Li X; Run X; Liang Z; Li Y; Liu Y; Lee MH; Grundke-Iqbal I; Iqbal K; Vocadlo DJ; Liu F; Gong CX
    PLoS One; 2012; 7(4):e35277. PubMed ID: 22536363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-8719, a Novel and Selective
    Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
    J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
    Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
    Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice.
    Pan D; Gu JH; Zhang J; Hu Y; Liu F; Iqbal K; Cekic N; Vocadlo DJ; Dai CL; Gong CX
    J Alzheimers Dis; 2021; 81(1):273-286. PubMed ID: 33814439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer's disease and related tauopathies: analysis of the patent literature.
    Bartolomé-Nebreda JM; Trabanco AA; Velter AI; Buijnsters P
    Expert Opin Ther Pat; 2021 Dec; 31(12):1117-1154. PubMed ID: 34176417
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
    Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
    Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent paclitaxel.
    Ding N; Ping L; Shi Y; Feng L; Zheng X; Song Y; Zhu J
    Biochem Biophys Res Commun; 2014 Oct; 453(3):392-7. PubMed ID: 25268318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
    Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
    PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar Kick Prevents Memory Impairment.
    Rudrawar S; Ryan P
    J Med Chem; 2019 Nov; 62(22):10059-10061. PubMed ID: 31668062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
    Huang R; Tian S; Zhang H; Zhu W; Wang S
    Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.
    Li X; Han J; Bujaranipalli S; He J; Kim EY; Kim H; Im JH; Cho WJ
    Eur J Med Chem; 2022 Aug; 238():114444. PubMed ID: 35588599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc modification and the tauopathies: insights from chemical biology.
    Yuzwa SA; Vocadlo DJ
    Curr Alzheimer Res; 2009 Oct; 6(5):451-4. PubMed ID: 19874270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
    Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
    Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaminocyclopentane-derived
    Weber P; Mészáros Z; Jagečić D; Hribljan V; Mitrečić D; Bojarová P; Slámová K; Vrba J; Kulik N; Křen V; Stütz AE
    Chem Commun (Camb); 2022 Aug; 58(63):8838-8841. PubMed ID: 35849011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide
    Cheng Z; Shang N; Wang X; Kang Y; Zhou J; Lan J; Hu J; Peng Y; Xu B
    J Med Chem; 2024 Aug; 67(16):14292-14312. PubMed ID: 39109492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice.
    Borghgraef P; Menuet C; Theunis C; Louis JV; Devijver H; Maurin H; Smet-Nocca C; Lippens G; Hilaire G; Gijsen H; Moechars D; Van Leuven F
    PLoS One; 2013; 8(12):e84442. PubMed ID: 24376810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing O-GlcNAcylation Attenuates tau Hyperphosphorylation and Behavioral Impairment in rTg4510 Tauopathy Mice.
    Rostgaard N; Jul PH; Garmer M; Volbracht C
    J Integr Neurosci; 2023 Sep; 22(5):135. PubMed ID: 37735138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells.
    Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H
    Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.